In older patients, this is important to comprehend as polypharmacy is common and will potentiate the risk of DDIs and ADRs. As a result, concurrent ingestion of CYP2D6 inhibitors or inducers could potentiate or block tramadol conversion into ODT and this could raise or lower efficacy/ADRs from the prescribed https://noeln504nsv4.wikiconverse.com/user